Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later

Simple item page

Simple item page

Full item details

creativework.keywords - en
COVID-19
pediatric multisystem inflammatory syndrome
multisystem inflammatory syndrome in children
MIS-C
PIMS
PIMS-TS
dc.contributor.author
Striha, Megan
Edjoc, Rojiemiahd
Bresee, Natalie
Atchessi, Nicole
Waddell, Lisa
Bennett, Terri-Lyn
Thompson, Emily
Jaouhari, Maryem
Bonti-Ankomah, Samuel
dc.date.accessioned
2024-04-02T15:02:34Z
dc.date.available
2024-04-02T15:02:34Z
dc.date.issued
2021-11
dc.description.abstract - en
BACKGROUND : Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) is an emerging condition that was first identified in paediatrics at the onset of the COVID-19 pandemic. The condition is also known as pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS or PIMS), and multiple definitions have been established for this condition that share overlapping features with Kawasaki Disease and toxic shock syndrome. METHODS: A review was conducted to identify literature describing the epidemiology of MIS-C, published up until March 9, 2021. A database established at the Public Health Agency of Canada with COVID-19 literature was searched for articles referencing MIS-C, PIMS or Kawasaki Disease in relation to COVID-19. RESULTS: A total of 195 out of 988 articles were included in the review. The median age of MIS-C patients was between seven and 10 years of age, although children of all ages (and adults) can be affected. Multisystem inflammatory syndrome in children disproportionately affected males (58% patients), and Black and Hispanic children seem to be at an elevated risk for developing MIS-C. Roughly 62% of MIS-C patients required admission to an intensive care unit, with one in five patients requiring mechanical ventilation. Between 0% and 2% of MIS-C patients died, depending on the population and available interventions. CONCLUSION: Multisystem inflammatory syndrome in children can affect children of all ages. A significant proportion of patients required intensive care unit and mechanical ventilation and 0%-2% of cases resulted in fatalities. More evidence is needed on the role of race, ethnicity and comorbidities in the development of MIS-C.
dc.identifier.citation
Striha M, Edjoc R, Bresee N, Atchessi N, Waddell L, Bennett TL, Thompson E, El Jaouhari M, Bonti-Ankomah S. Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later. Can Commun Dis Rep. 2021 Nov 10;47(11):466-472. doi: 10.14745/ccdr.v47i11a04.
dc.identifier.doi
https://doi.org/10.14745/ccdr.v47i11a04
dc.identifier.issn
1481-8531
dc.identifier.pubmedID
34880708
dc.identifier.uri
https://open-science.canada.ca/handle/123456789/2211
dc.language.iso
en
dc.publisher
Public Health Agency of Canada
dc.rights - en
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights - fr
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights.uri - en
https://creativecommons.org/licenses/by/4.0/
dc.rights.uri - fr
https://creativecommons.org/licenses/by/4.0/deed.fr
dc.subject - en
Health
dc.subject - fr
Santé
dc.subject.en - en
Health
dc.subject.fr - fr
Santé
dc.title - en
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
dc.type - en
Article
dc.type - fr
Article
local.article.journalissue
11
local.article.journaltitle
Canada Communicable Disease Report
local.article.journalvolume
10
local.pagination
466-472
local.peerreview - en
Yes
local.peerreview - fr
Oui
Download(s)

Original bundle

Now showing 1 - 1 of 1

Thumbnail image

Name: striha-multisystem-inflammatory-syndrome-paediatric.pdf

Size: 418.75 KB

Format: PDF

Download file

Page details

Date modified: